Studies on 3-diethylaminocarbonyl-1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium channel antagonistic activities in vitro

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 7, 2004, Pages 371-375

  Kismetli, Emrah ^a   Şafak, Cihat ^a   Erol, Kevser ^b   Sirmagül, Başar ^b   Linden, Anthony ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Calcium antagonists; CAS 55985 32 5; Hexahydroquinolines, calcium antagonist activity, in vitro studies, synthesis; Nicardipine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NICARDIPINE; QUINOLINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; ILEUM; INFRARED RADIATION; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RAT;

EID: 3242786320     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296986     Document Type: Article

References (16)

1. +2 channel antagonists and activators: A comparison of binding characteristics with pharmacology. Drug Develop. Res. 4, 257 (1984)
2. 2+ channel antagonists. J. Med. Chem. 26, 775 (1983)
3. Flaim, S. F., Zelis, R., Comparative cardiac pharmacology of calcium blockers, In: Calcium blockers: Mechanisms of Action and Clinical Applications. Urban & Schwarzenberg, Baltimore (1982)
4. Godfraind, T., Miller, R., Wibo, M., Calcium antagonism and calcium entry blockade. Pharmacol. Rev. 38, 321 (1986)
5. Altaş, Y., Şafak, C., Batu, O. S. et al., Studies on calcium modulatory activities of 2,6,6-trimethyl-3-acetyl-4-aryl-5-oxo-1,4,5,6, 7,8-hexahydroquinoline derivatives. Arzneim.-Forsch./Drug Res. 49 (I), 824 (1980)
6. Şafak, C., Özkanli, F., Erol, K. et al., 3-Acetyl-4-aryl-5- oxo-2,7,7-trimethyl-1,4,5,6,7,8-hexahydro-quinoline derivatives and their calcium antagonistic activities. Arzneim. Forsch./Drug Res. 45 (II), 1154 (1980)
7. Rose, U., Synthesis and pharmacological activities of calcium modulatory hexahydroquinolinones. Arzneim.-Forsch./Drug Res. 41 (I), 199 (1991)
8. Rose, U., Kalzium-Modulatoren vom Typ anellierter Dihydropyridin/Synthese und pharmakologische Wirkung. Arzneim.-Forsch./Drug Res. 39 (II), 1393 (1989)
9. Şafak, C., Erdemli, İ., Sunal, R., Synthesis of some 1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium antagonistic activities. Arzneim.-Forsch./Drug Res. 43 (II), 1052 (1993)
10. Rose, U., Hexahydrochinolinone mit calciummodulatorischem Effekt/Synthese und pharmakologische Wirkung. Arch. Pharm. 323, 281 (1990)
11. Rose, U., 5-Oxo-1,4-dihydroindenopyridines: Calcium modulators with partial calcium agonistic activity. J. Hetero. Chem. 27, 237 (1989)
12. Şimşek, R., Şafak, C., Erol, K. et al., Synthesis, evaluation of the calcium antagonistic activity and biotransformation of hexahydroquinoline and furoquinoline derivatives possessing calcium modulating activity. Arzneim.-Forsch./Drug Res. 53, 159 (2003)
13. Langs, D. A., Triggle, D. J., Conformational features of calcium channel agonist and antagonist analogs of nifedipine. Mol. Pharmacol. 27, 544 (1985)
14. Franckowiak, G., Bechem, M., Schramm, M., et al., The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels. Eur. J. Pharmacol. 114, 223 (1985)
15. Hantzsch, A., Justus Liebigs Ann. Chem. 215, 1 (1882)
16. Linden, A., Şafak, C., Kismetli, E., N,N-Diethyl-2,6,6-trimethyl- 4-(3-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide. Acta Crystall. Sect. C 58, 436 (2002)